Elekta AB


Pressmeddelande   •   Okt 17, 2005 09:14 CEST

Mountain View, Calif., October 17, 2005

IMPAC Medical Systems, Inc., part of the Elekta Group and a leading provider of information technology solutions for oncology care, has named Gerald L. (Gerry) Hogue as Vice President, Professional Services. Mr. Hogue was the founder of OpTx Corporation, formerly IMPAC’s major competitor in the medical oncology arena. He brings significant oncology and pharmaceutical market knowledge and access, and rich functional skills and methodologies in oncology and IT management, systems implementation, process change management and clinical trials to IMPAC/Elekta.

Prior to starting OpTx in 1993, Mr. Hogue was Managing Partner of the Western Canada information technology consulting practice for Price Waterhouse Management Consultants. James Hoey, President and CEO of IMPAC, is pleased to welcome Mr. Hogue to IMPAC/Elekta. “Our clients and prospects have been asking us to provide broad professional services to further enhance our integrated technology product offerings. The wealth of experience and credibility that Gerry brings in this area will allow us to kick-start our strategic services organization and focus immediately on a previously underserved market segment.”

Mr. Hogue added “I’m very excited to join IMPAC. Its fully integrated oncology management solutions are second-to-none, and provide clients with the technology platform needed to fully integrate technology with care delivery and business processes to achieve step changes in clinical and operational efficiency and outcomes and position cancer care delivery and research organizations for the future. Our professional services, which will be marketed under the brand name STRATEGIQ™, will allow IMPAC/Elekta to broaden and strengthen its fully integrated IQ™ line of technology products and assist practitioners to realize additional benefits from enabling technologies.”

Demonstrations of IMPAC’s IQ line of technology products will be available at IMPAC’s booth # 1122 during the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver, Colorado, October 16-19, 2005.


For more information, please contact:

Julie DeSantis
Public Relations Manager, IMPAC Medical Systems, Inc.
Tel: +1 650 623 8883, e-mail: jdesantis@impac.com

Investor inquiries, International:

Peter Ejemyr
Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000
e-mail: peter.ejemyr@elekta.com

Investor inquiries, United States:

Lars Jonsteg
VP Investor Relations North America, Elekta, USA
Tel: +46 708 78 37 35
e-mail: lars.jonsteg@elekta.com

About IMPAC Medical Systems

IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care. For more information about IMPAC’s products or services, please call 888-GO-IMPAC or visit www.impac.com.

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. With approx. 1700 employees, Elekta’s corporate headquarters is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta’s products or services, please visit www.elekta.com.